NCT05827341 A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials Status COMPLETED Phase N/A
NCT05822583 Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial Status COMPLETED Phase PHASE4
NCT05822219 Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases Status ACTIVE_NOT_RECRUITING Phase NA
NCT05817045 Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19 Status COMPLETED Phase NA
NCT05815498 A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 Status COMPLETED Phase PHASE3
NCT05815485 A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05812586 Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes. Status UNKNOWN Phase PHASE3
NCT05808413 Exploring the Effect of Video Interventions on Intentions for Continued COVID-19 Vaccination Status COMPLETED Phase NA
NCT05808322 Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities Status UNKNOWN Phase PHASE2/PHASE3
NCT05808231 Effectiveness and Safety of Quinine Sulfate as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia ( DEAL-COVID19 ) Status UNKNOWN Phase NA
NCT05803395 Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy. Status RECRUITING Phase N/A
NCT05802875 Building Resilience During the COVID-19 Pandemic: a Randomized Controlled Trial Status RECRUITING Phase NA